Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Key Inclusion Criteria:

• Study candidate is undergoing a temporary SCS trial of commercially approved BSCneurostimulator system, per local directions for use (DFU).

• Subject signed a valid, EC/IRB-approved informed consent form.

• Age 18 or above, or above legal age and willing and capable of giving informedconsent specific to national law when written informed consent is obtained.

• In the clinician best judgment, subject is able to distinguishably describe qualityand location of sensation and pain.

Key Exclusion Criteria:

• Subject meets any contraindication in BSC neurostimulation system local DFU.

• Investigator-suspected gross lead migration during the SCS trial period which maypreclude the study candidate from receiving adequate SCS therapy.

• Subject is currently diagnosed with cognitive impairment, or exhibits anycharacteristic, that in the clinician's best judgement would limit study candidate'sability to assess and report sensation information.

• Subject is currently diagnosed with a physical impairment, or exhibits a conditionthat would limit study candidate's ability to complete study assessments.